|
Real-time Estimate
Cboe Europe
08:13:23 17/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 39.60 DKK | +0.64% |
|
-9.28% | +9.39% |
| 11/09 | Lundbeck's Asedebart Gets US FDA Orphan Drug Designation for Endogenous Cushing's Syndrome | MT |
| 11/09 | Lundbeck wins US orphan drug status for asedebart in Cushing's syndrome | FW |
Chart: Technical Analysis
Nasdaq CopenhagenDKK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| LUN | Delayed | |
CBOE
| LUNc | Real-time | |
|
London S.E.
| 0ABR | Delayed | |
|
OTC Markets
| HLUBF | Delayed | |
|
Tradegate
| LDBB | Real-time | |
|
Wiener Boerse
| LUNA | End-of-day quote | |
|
Deutsche Boerse AG
| LDBB | Delayed | |
|
CBOE
| 0ABR | Real-time | |
|
Börse Stuttgart
| LDBB | Delayed | |
|
Boerse Muenchen
| LDBB | Real-time | |
Nasdaq Copenhagen
| HLUN B | Delayed | |
|
CBOE
| Real-time | ||
|
London S.E.
| 0ND5 | Delayed | |
|
CBOE
| 0ND5 | Real-time | |
|
OTC Markets
| HLBBF | Delayed | |
|
Tradegate
| LDBA | Real-time | |
|
Wiener Boerse
| LUNB | End-of-day quote | |
|
Deutsche Boerse AG
| LDBA | Delayed | |
|
Boerse Muenchen
| LDBA | Real-time | |
|
Börse Stuttgart
| LDBA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 43.95 | 43.95 | 43.85 |
| Spread/Res. | -9.90% | -9.90% | -9.69% |
| Spread/Supp. | +7.90% | +7.90% | +5.60% |
| Support | 36.7 | 36.7 | 37.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- HLUN B Stock
- LUN Stock
- Charts Lundbeck
Select your edition
All financial news and data tailored to specific country editions
